<DOC>
	<DOCNO>NCT03091504</DOCNO>
	<brief_summary>High-humidity nasal cannula ( HFNC ) show effective improve oxygenation avoid intubation multiple randomize control trial , also suitable feasible long term use . Aerosol delivery via HFNC minimize interruption improve patient compliance , bench study radionuclide image study do healthy volunteer demonstrate aerosol effectively deliver use HFNC . This study aim evaluate efficacy bronchodilator deliver via HFNC chronic pulmonary obstructive disease asthma patient .</brief_summary>
	<brief_title>Evaluation Efficacy Bronchodilator Nebulization Via High Flow Nasal Cannula</brief_title>
	<detailed_description>Chronic obstructive pulmonary disease asthma patient positive response bronchodilator test consent enrolled , patient come back second bronchodilator assessment within one three day initial bronchodilator test . Albuterol different concentration provide patient via HFNC , patient assess spirometry concentration bronchodilator response positive improve next dose .</detailed_description>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Diagnose COPD asthma Bronchodilator test positive ( According ATS guideline , FEV1 change initial 12 % FEV1 absolute change 200 mL ) ; Age &gt; 18yrs &lt; 90yrs Recent pulmonary exacerbation Mental disease Uncooperative Reluctant participate Patients unable come back get second spirometry within three day Contraindicated Albuterol ( Ventolin , GSK ) Rest HR &gt; 100 beats/min Serum K+ &lt; 2.8 mmol/L</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>